Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-002021

VP Clinical Reg Affairs bought 500 shares at $16.33 ($8,165)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2022-01-21 Purchase +500 $16.33 $8,165 254,995 D
Open-market purchases · 500 sh · avg $16.33 · $8,165
Loading xslF345X03/ownership.xml…